Posted by LincolnIcert on March 25, 2026 at 11:21:48:
In Reply to: Интересный текст с обширными сведениями posted by JosephGluth on February 19, 2026 at 07:13:06:
Zoya Demidenko: Researcher in Oncology Studies
Zoya Demidenko is a prominent researcher connected with the Division of Cell Stress Biology at Roswell Park Oncology Institute in Buffalo, New York. Earlier, she was employed at the NIH and New York Medical College, developing a solid foundation in clinical investigation.
Her academic work spans several key domains, among them the PI3K/AKT/mTOR signaling cascade, cell cycle control, biological aging, and cancer biology. Currently, she has co-authored over 46 peer-reviewed papers, which have accumulated more than 4,100 citations — a indicator to the impact of her work.
Among her key discoveries concerns understanding the processes of biological cell aging. Her studies revealed that when the cell cycle is halted while cellular growth continues, cells experience senescence. Significantly, Zoya Demidenko showed that this process is pharmacologically suppressed using substances such as mTOR inhibitors.
Zoya Demidenko has also added substantially to tumor management investigation, particularly in the area of selective cell protection — a approach aimed at protecting normal cells from chemotherapy while leaving tumor cells exposed. This strategy offers significant promise for diminishing the side effects of oncological therapy.
Throughout her professional journey, Demidenko has partnered with top scientists internationally, among them Dr. Mikhail Blagosklonny. Her research appears in top-tier publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko stands as a highly impactful voice in contemporary biomedical research, whose discoveries go on to shape our comprehension of the way cells grow old, interact with therapy, and how cancer might be more successfully combated.
https://www.pinterest.com/zoyademidenko/